OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
May 11, 2015
A vaccine patch may eliminate the need for traditional means of vaccine distribution, according to an article in NPR.
May 07, 2015
The US Court of Appeals granted Amgen’s request to block Novartis’ Neupogen biosimilar, Zarxio, from the US market until the court resolves litigation between the two companies.
May 06, 2015
Eleven of the leading US biosimilar developers have collaborated to form the Biosimilars Forum, a nonprofit organization formed to expand patient access to biosimilars.
May 04, 2015
Advances in transdermal drug delivery, particularly with microneedles, are enabling a wider range of drugs to be delivered through the skin.
Capsugel extends inhaled biotherapeutics delivery capability to Phase 2 clinical trials.
Intellectual property lawyers estimate biosimilar litigation will swell as early as 2018.
May 02, 2015
While the United States and Europe still dominate, CMOs and CROs based in emerging markets continue to capture market share.
Adjusting the tablet press and its systems can prevent manufacturing and product quality problems.
The European Pharmacopoeia defines the format and content of monographs for biologicals to keep pace with recent approaches and meet the needs of its users.
April 28, 2015
Mylan announces a recall of eight lots of injectable products due to visible foreign particulate matter.
